Christopher Flint Obrien - Net Worth and Insider Trading

Christopher Flint Obrien Net Worth

The estimated net worth of Christopher Flint Obrien is at least $7 Million dollars as of 2024-11-13. Christopher Flint Obrien is the Former Chief Medical Officer of Neurocrine Biosciences Inc and owns about 55,946 shares of Neurocrine Biosciences Inc (NBIX) stock worth over $7 Million. Details can be seen in Christopher Flint Obrien's Latest Holdings Summary section.

Disclaimer: The insider information is derived from SEC filings. The estimated net worth is based on the final shares held after open market or private purchases and sales of common stock with a transaction code of "P" or "S" on Form 4, assuming that Christopher Flint Obrien has not made any transactions after 2018-02-05 and currently still holds the listed stock(s). Please note that this estimate may not reflect the actual net worth.

Transaction Summary of Christopher Flint Obrien

Christopher Flint Obrien Insider Ownership Reports

Based on ownership reports from SEC filings, as the reporting owner, Christopher Flint Obrien owns 1 companies in total, including Neurocrine Biosciences Inc (NBIX) .

Click here to see the complete history of Christopher Flint Obrien’s form 4 insider trades.

Insider Ownership Summary of Christopher Flint Obrien

Ticker	Comapny	Transaction Date	Type of Owner
NBIX	Neurocrine Biosciences Inc	2018-02-05	Sr. VP & Chief Medical Officer

Christopher Flint Obrien Latest Holdings Summary

Christopher Flint Obrien currently owns a total of 1 stock. Christopher Flint Obrien owns 55,946 shares of Neurocrine Biosciences Inc (NBIX) as of February 5, 2018, with a value of $7 Million.

Latest Holdings of Christopher Flint Obrien

Ticker	Comapny	Latest Transaction Date	Shares Owned	Current Price ($)	Current Value ($)
NBIX	Neurocrine Biosciences Inc	2018-02-05	55,946	125.51	7,021,782

Holding Weightings of Christopher Flint Obrien

Christopher Flint Obrien Form 4 Trading Tracker

According to the SEC Form 4 filings, Christopher Flint Obrien has made a total of 0 transactions in Neurocrine Biosciences Inc (NBIX) over the past 5 years. The most-recent trade in Neurocrine Biosciences Inc is the sale of 2,613 shares on February 5, 2018, which brought Christopher Flint Obrien around $217,349.

Insider Trading History of Christopher Flint Obrien

No transactions are available. GuruFocus only tracks and displays the purchase and sale of non-derivative security in open market or private transactions from SEC filings with the transaction code of P or S.

Total 0

Only the transactions in Open Market or Private Sale at the market prices are included. Other transactions such as conversion of derivative security or exercise of options are not included. Insiders are limited to only officers and/or directors of the company.

Christopher Flint Obrien Trading Performance

Please note GuruFocus will not track the insiders’ transaction performance if he/she does not have buying transactions.

Christopher Flint Obrien Ownership Network

Ownership Network List of Christopher Flint Obrien

No Data

Ownership Network Relation of Christopher Flint Obrien

Christopher Flint Obrien Owned Company Details

What does Neurocrine Biosciences Inc do?

Who are the key executives at Neurocrine Biosciences Inc?

Christopher Flint Obrien is the Sr. VP & Chief Medical Officer of Neurocrine Biosciences Inc. Other key executives at Neurocrine Biosciences Inc include Chief Corp. Affairs Officer David W. Boyer , Chief Regulatory Officer Ingrid Delaet , and Chief Financial Officer Matt Abernethy .

Neurocrine Biosciences Inc (NBIX) Insider Trades Summary

Over the past 18 months, Christopher Flint Obrien made no insider transaction in Neurocrine Biosciences Inc (NBIX). Other recent insider transactions involving Neurocrine Biosciences Inc (NBIX) include a net sale of 32,776 shares made by Ingrid Delaet , a net sale of 58,181 shares made by Darin Lippoldt , and a net sale of 55,568 shares made by Julie Cooke .

In summary, during the past 3 months, insiders sold 19,006 shares of Neurocrine Biosciences Inc (NBIX) in total and bought 0 shares, with a net sale of 19,006 shares. During the past 18 months, 993,959 shares of Neurocrine Biosciences Inc (NBIX) were sold and 0 shares were bought by its insiders, resulting in a net sale of 993,959 shares.

Neurocrine Biosciences Inc (NBIX)'s detailed insider trading history can be found in Insider Trading Tracker table.

Neurocrine Biosciences Inc Insider Transactions

No Available Data

Christopher Flint Obrien Mailing Address

Above is the net worth, insider trading, and ownership report for Christopher Flint Obrien. You might contact Christopher Flint Obrien via mailing address: 12790 El Camino Real, San Diego Ca 92130.

Research Tools

All-In-One Screener Stock Ideas Stock List Guru List Guru Real-Time Picks Insider List Insider Trades Economic Indicators Sector & Industry Performance DCF Calculator Discussion Board

Product

Pricing Plans Excel Add-In Google Sheets Add-on Data API Stock Comparison Table Manual of Stocks Instant Alerts Mobile App 中文

Education

Financial Glossary Tutorials FAQ Schedule Free Session Buffett Indicator Shiller P/E Yield Curve Today U.S. Inflation Rate Global Market Valuation Fed Net Liquidity Buffett Assets Allocation

Company

About GuruFocus Career Contact Us Advertise Site Map Term of Use Privacy Policy Referral Program Partner Program

Survey

We'd love to learn more about your experiences on GuruFocus.com and how we can improve!

Take Survey

Disclaimers

GuruFocus.com is not operated by a broker or a dealer. Under no circumstances does any information posted on GuruFocus.com represent a recommendation to buy or sell a security. The information on this site, and in its related newsletters, is not intended to be, nor does it constitute investment advice or recommendations. The individuals or entities selected as "gurus" may buy and sell securities before and after any particular article and report and information herein is published, with respect to the securities discussed in any article and report posted herein. Gurus may be added or dropped from the GuruFocus site at any time. In no event shall GuruFocus.com be liable to any member, guest or third party for any damages of any kind arising out of the use of any content or other material published or available on GuruFocus.com, or relating to the use of, or inability to use, GuruFocus.com or any content, including, without limitation, any investment losses, lost profits, lost opportunity, special, incidental, indirect, consequential or punitive damages. Past performance is a poor indicator of future performance. The information on this site, and in its related newsletters, is not intended to be, nor does it constitute investment advice or recommendations. The information on this site is in no way guaranteed for completeness, accuracy or in any other way. The gurus listed in this website are not affiliated with GuruFocus.com, LLC. Stock quotes are provided by QuoteMedia, Inc. (CSI). Company fundamental data is provided by Morningstar. Analyst estimates data is sourced from both Refinitiv and Morningstar, with priority given to Refinitiv data. Data is updated daily.